[GnRH antagonists in gynecology: initial results within the scope of controlled ovarian hyperstimulation].
Applicability of the GnRH-antagonist Cetrorelix within controlled ovarian hyperstimulation (COH) to avoid the premature LH-surge should be examined. 35 patients suffering from tubal infertility were stimulated for In Vitro Fertilization (IVF) by human menopausal gonadotrophins (HMG) and concomitant administration of Cetrorelix in different dosages (3 mg, 1 mg, 0,5 mg). No premature LH-surge could be observed. Short term administration of the GnGR-antagonists avoids the occurrence of a premature LH-surge.